Choosing the right mouse model for diabetic nephropathy

Kidney International

Volumn 77, Issue 9, 2010, Pages 749-750

  Schlöndorff, Detlef ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; C57BL 6 MOUSE; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA MODIFICATION; EDITORIAL; EXPERIMENTAL MODEL; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

EID: 77951053907     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.545     Document Type: Editorial

References (12)

1. Iyengar SK, Abboud HE, Goddard KA et al. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 2007; 56: 1577-1585.
2. Breyer MD, Bottinger E, Brosius FC III et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005; 16: 27-45. (Pubitemid 43073154)
3. Brosius FC III, Alpers CE, Bottinger EP et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2009; 20: 2503-2512.
4. Qi Z, Fujita H, Jin J et al. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 2005; 54: 2628-2637. (Pubitemid 41233584)
5. Gurley SB, Clare SE, Snow KP et al. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 2006; 290: F214-F222.
6. Rivera J, Tessarollo L. Genetic background and the dilemma of translating mouse studies to humans. Immunity 2008; 28: 1-4.
7. Wolfer D P, Crusio WE, Lipp H-P. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 2002; 25: 336-341.
8. Naggert JK, Mu JL, Frankel W et al. Genomic analysis of the C57BL/Ks mouse strain. Mamm Genome 1995; 6: 131-133.
9. Nakagawa T, Sato W, Glushakova O et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550. (Pubitemid 46193319)
10. Kanetsuna Y, Takahashi K, Nagata M et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 2007; 170: 1473-1484. (Pubitemid 47339294)
11. Zhao HJ, Wang S, Cheng H et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006; 17: 2664-2669. (Pubitemid 44484656)
12. Kakoki M, Takahashi N, Jennette JC, Smithies O. Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci USA 2004; 101: 13302-13305. (Pubitemid 39209660)